AIFM2 and cancer: Interestingly, pharmacological inhibitors of FSP1 such as iFSP1 synergizes with GPX4 modulation to trigger ferroptosis in FSP1 overexpressed cells [76,77], and iFSP1 can sensitize several cancer cells to ferroptosis [78].